BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 33121444)

  • 1. Community-dwelling older adults' awareness of the inappropriate use of proton pump inhibitors.
    Rababa M; Rababa'h A
    BMC Geriatr; 2020 Oct; 20(1):431. PubMed ID: 33121444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients' Perceptions of Proton Pump Inhibitor Risks and Attempts at Discontinuation: A National Survey.
    Kurlander JE; Kennedy JK; Rubenstein JH; Richardson CR; Krein SL; De Vries R; Saini SD
    Am J Gastroenterol; 2019 Feb; 114(2):244-249. PubMed ID: 30694867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
    Freedberg DE; Kim LS; Yang YX
    Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing.
    Dharmarajan TS
    J Am Med Dir Assoc; 2021 Jan; 22(1):15-22. PubMed ID: 33321078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate Use of Proton Pump Inhibitor Among Elderly Patients in British Columbia: What are the Long-term Adverse Events?
    Ben-Eltriki M; Chhabra M; Cassels A; Wright JM
    Curr Drug Saf; 2024; 19(2):244-247. PubMed ID: 37496243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.
    Targownik LE; Fisher DA; Saini SD
    Gastroenterology; 2022 Apr; 162(4):1334-1342. PubMed ID: 35183361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Value Proton Pump Inhibitor Prescriptions Among Older Adults at a Large Academic Health System.
    Mafi JN; May FP; Kahn KL; Chong M; Corona E; Yang L; Mongare MM; Nair V; Reynolds C; Gupta R; Damberg CL; Esrailian E; Sarkisian C
    J Am Geriatr Soc; 2019 Dec; 67(12):2600-2604. PubMed ID: 31486549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.
    Gyawali CP
    Curr Gastroenterol Rep; 2017 Sep; 19(9):46. PubMed ID: 28780717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inappropriate use of proton pump inhibitors and its associated factors among community-dwelling older adults.
    Rababa M; Rababa'h A
    Heliyon; 2021 Jul; 7(7):e07595. PubMed ID: 34337188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.
    Scarpignato C; Gatta L; Zullo A; Blandizzi C; ;
    BMC Med; 2016 Nov; 14(1):179. PubMed ID: 27825371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
    Björnsson E; Abrahamsson H; Simrén M; Mattsson N; Jensen C; Agerforz P; Kilander A
    Aliment Pharmacol Ther; 2006 Sep; 24(6):945-54. PubMed ID: 16948806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors: the good, the bad, and the unwanted.
    Chubineh S; Birk J
    South Med J; 2012 Nov; 105(11):613-8. PubMed ID: 23128806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
    Higginbotham TW
    Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review.
    van der Pol RJ; Smits MJ; van Wijk MP; Omari TI; Tabbers MM; Benninga MA
    Pediatrics; 2011 May; 127(5):925-35. PubMed ID: 21464183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebound Acid Hypersecretion after Withdrawal of Long-Term Proton Pump Inhibitor (PPI) Treatment-Are PPIs Addictive?
    Namikawa K; Björnsson ES
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease.
    Shi YC; Cai ST; Tian YP; Zhao HJ; Zhang YB; Chen J; Ren RR; Luo X; Peng LH; Sun G; Yang YS
    Genomics Proteomics Bioinformatics; 2019 Feb; 17(1):52-63. PubMed ID: 31028880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicians' Perceptions of Proton Pump Inhibitor Risks and Recommendations to Discontinue: A National Survey.
    Kurlander JE; Rubenstein JH; Richardson CR; Krein SL; De Vries R; Zikmund-Fisher BJ; Yang YX; Laine L; Weissman A; Saini SD
    Am J Gastroenterol; 2020 May; 115(5):689-696. PubMed ID: 32091419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of proton pump inhibitors in children: a comprehensive review.
    Gibbons TE; Gold BD
    Paediatr Drugs; 2003; 5(1):25-40. PubMed ID: 12513104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.